Wells Fargo Maintains Overweight on iRhythm Holdings, Lowers Price Target to $168
Wells Fargo analyst Nathan Treybeck maintains iRhythm Holdings (NASDAQ:IRTC) with a Overweight and lowers the price target from $180 to $168.
Read original at benzingaStocks · News reference
iRhythm To Acquire Maker Of Wearable Biosensor And Ambulatory Cardiac Monitoring Technology Vital Connect For ~$237.5M In Cash And ~$50M In IRTC Stock
Upon closing, the transaction is expected to immediately expand iRhythm's addressable market and advance its evolution into a broader cardiac monitoring and intelligence platform. VitalConnect includes an
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Aug 6, 2026, 8:40 PM
- Checked
- Aug 6, 2026, 8:40 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
8-K filing — iRhythm Holdings, Inc. (IRTC)
Filed: 2026-08-13 AccNo: 0001388658-26-000076 Size: 140 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Read original at edgarTruist Securities Maintains Buy on iRhythm Holdings, Raises Price Target to $168
Truist Securities analyst Richard Newitter maintains iRhythm Holdings (NASDAQ:IRTC) with a Buy and raises the price target from $160 to $168.
Read original at benzingaiRhythm Combines Strong Performance with VitalConnect Buy to Expand Remote Cardiac Care
iRhythm to acquire VitalConnect for $287.5 million, expands cardiac monitoring portfolio after Q2 earnings beat and higher fiscal 2026 guidance.
Read original at benzinga